Cuál es el precio por Novartis AG (NVS)

Precio por Novartis AG (NVS) es de$150.75

Cuál es la capitalización de mercado por Novartis AG (NVS)

Capitalización de mercado por Novartis AG (NVS) es $291.41B

Novartis AG (NVS) EPS

Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatology, respiratory, cardiovascular, renal, and metabolism medicine products. The Sandoz segment develops, manufactures, and markets finished dosage form medicines; active ingredients and finished dosage forms of small molecule pharmaceuticals to third parties; and retail generics and anti-infectives. It also provides active pharmaceutical ingredients and intermediates primarily antibiotics; protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran; and a clinical collaboration with Kura Oncology, Inc. to evaluate the combination of Tipifarnib and Alpelisib in patients with head and neck squamous cell carcinoma. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.

Año	EPS	Cambiar
Not enough data for the provided dates.

Año

EPS

Cambiar

Not enough data for the provided dates.

Empresa	EPS	Diferencia de EPS	País
Eli Lilly LLY.US	$23.00	-	US
AstraZeneca PLC AZN.US	$13.20	-	GB
Johnson & Johnson JNJ.US	$11.10	-	US
AbbVie Inc. ABBV.US	$2.37	-	US
Merck & Co., Inc. MRK.US	$7.30	-	US

Empresa

EPS

Diferencia de EPS

País